At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. Together, we partner with customers to solve their toughest challenges—with speed and certainty.
Looking for a particular abcam employee's phone or email?
The abcam annual revenue was $232.5 million in 2026.
David Hughes is the Vice President Research and Innovation of abcam.
1,265 people are employed at abcam.